These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cisplatin, tegafur, and leucovorin: a moderately effective and minimally toxic outpatient neoadjuvant chemotherapy for locally advanced squamous cell carcinoma of the head and neck. Wang HM, Wang CS, Chen JS, Chen IH, Liao CT, Chang TC. Cancer; 2002 Jun 01; 94(11):2989-95. PubMed ID: 12115388 [Abstract] [Full Text] [Related]
3. Biweekly paclitaxel, cisplatin, tegafur, and leucovorin as neoadjuvant chemotherapy for unresectable squamous cell carcinoma of the head and neck. Wang HM, Liao CT, Chang TC, Chen JS, Liaw CC, Chen IH, Tsang NM. Cancer; 2004 Oct 15; 101(8):1818-23. PubMed ID: 15386306 [Abstract] [Full Text] [Related]
4. Concurrent chemoradiotherapy using cisplatin, tegafur, and leucovorin for advanced squamous cell carcinoma of the hypopharynx and oropharynx. Wang HM, Hsu CL, Hsieh CH, Fan KH, Lin CY, Chang JT, Huang SF, Chen IH, Liao CT, Ng SK. Biomed J; 2014 Oct 15; 37(3):133-40. PubMed ID: 24923571 [Abstract] [Full Text] [Related]
5. Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M. D. Anderson Cancer Center experience. Shirinian MH, Weber RS, Lippman SM, Dimery IW, Earley CL, Garden AS, Michaelson J, Morrison WH, Kramer A, Byers R. Head Neck; 1994 Oct 15; 16(1):39-44. PubMed ID: 7510276 [Abstract] [Full Text] [Related]
8. [Induction chemotherapy using vinorelbine, cisplatin, and UFT in advanced pharyngeo-laryngeal carcinomas: results of a phase II study]. Rubio Suárez A, Teigeiro Núñez V, Gallo Terán J, Señaris González B, Mesuro Domínguez N. Acta Otorrinolaringol Esp; 2003 Dec 15; 54(10):697-703. PubMed ID: 15164709 [Abstract] [Full Text] [Related]
9. Long-term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine, and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in a primary site preservation setting for resectable locally advanced squamous cell carcinoma of larynx and hypopharynx. Rivera F, Vega-Villegas ME, López-Brea MF, García-Castaño A, de Juan A, Collado A, Galdós P, Rubio A, del Valle A, Rama J, Sanz-Ortiz J. Laryngoscope; 2004 Jul 15; 114(7):1163-9. PubMed ID: 15235341 [Abstract] [Full Text] [Related]
10. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study. Chang PM, Chen PM, Chu PY, Wang LW, Tai SK, Tsai TL, Huang JL, Wang YF, Chang SY, Yang MH. Cancer Chemother Pharmacol; 2008 Dec 15; 63(1):9-17. PubMed ID: 18343925 [Abstract] [Full Text] [Related]
11. Neoadjuvant therapy with cisplatin/fluorouracil vs cisplatin/UFT in locally advanced squamous cell head and neck cancer. González-Larriba JL, Garcia Carbonero I, Sastre Valera J, Perez Segura P, Diaz-Rubio E. Oncology (Williston Park); 1997 Sep 15; 11(9 Suppl 10):90-7. PubMed ID: 9348577 [Abstract] [Full Text] [Related]
12. [Cytostatic primary therapy of squamous cell carcinoma of the oro- and hypopharynx with cisplatin, bleomycin and methotrexate]. Deitmer T, Urbanitz D. Laryngol Rhinol Otol (Stuttg); 1986 Jan 15; 65(1):7-10. PubMed ID: 2419720 [Abstract] [Full Text] [Related]
13. Efficacy of preoperative radiation therapy for resectable rectal adenocarcinoma when combined with oral tegafur-uracil modulated with leucovorin: results from a phase II study. Uzcudun AE, Batlle JF, Velasco JC, Sánchez Santos ME, Carpeño Jde C, Grande AG, Juberías AM, Piñeiro EH, Olivar LM, García AG. Dis Colon Rectum; 2002 Oct 15; 45(10):1349-58. PubMed ID: 12394434 [Abstract] [Full Text] [Related]
14. Phase II trial of uracil and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma. Pazdur R, Lassere Y, Rhodes V, Ajani JA, Sugarman SM, Patt YZ, Jones DV, Markowitz AB, Abbruzzese JL, Bready B. J Clin Oncol; 1994 Nov 15; 12(11):2296-300. PubMed ID: 7964943 [Abstract] [Full Text] [Related]
15. Concomitant b.i.d. radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in unresectable squamous-cell carcinoma of the pharynx: clinical and pharmacological data of a French multicenter phase II study. Bensadoun RJ, Etienne MC, Dassonville O, Chauvel P, Pivot X, Marcy PY, Prevost B, Coche-Dequeant B, Bourdin S, Vallicioni J, Poissonnet G, Courdi A, Teissier E, Lagrange JL, Thyss A, Santini J, Demard F, Schneider M, Milano G. Int J Radiat Oncol Biol Phys; 1998 Sep 01; 42(2):237-45. PubMed ID: 9788400 [Abstract] [Full Text] [Related]
16. Concomitant chemoradiotherapy using carboplatin, tegafur-uracil and leucovorin for stage III and IV head-and-neck cancer: results of GORTEC Phase II study. Fesneau M, Pointreau Y, Chapet S, Martin L, Pommier P, Alfonsi M, Laguerre B, Feham N, Berger C, Garaud P, Calais G. Int J Radiat Oncol Biol Phys; 2010 Jan 01; 76(1):154-63. PubMed ID: 19386430 [Abstract] [Full Text] [Related]
17. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience. Papadimitrakopoulou VA, Dimery IW, Lee JJ, Perez C, Hong WK, Lippman SM. Cancer J Sci Am; 1997 Jan 01; 3(2):92-9. PubMed ID: 9099459 [Abstract] [Full Text] [Related]
18. A phase II study of combined oral uracil and ftorafur with leucovorin for patients with squamous cell carcinoma of the head and neck. Colevas AD, Amrein PC, Gomolin H, Barton JJ, Read RR, Adak S, Benner S, Costello R, Posner MR. Cancer; 2001 Jul 15; 92(2):326-31. PubMed ID: 11466686 [Abstract] [Full Text] [Related]
19. Weekly low-dose docetaxel-based chemoradiotherapy for locally advanced oropharyngeal or hypopharyngeal carcinoma: a retrospective, single-institution study. Fukada J, Shigematsu N, Takeda A, Ohashi T, Tomita T, Shiotani A, Kunieda E, Kawaguchi O, Fujii M, Kubo A. Int J Radiat Oncol Biol Phys; 2010 Feb 01; 76(2):417-24. PubMed ID: 19409727 [Abstract] [Full Text] [Related]
20. The efficacy of epirubicin, cisplatin, uracil/tegafur, and leucovorin in patients with advanced biliary tract carcinoma. Park KH, Choi IK, Kim SJ, Oh SC, Seo JH, Choi CW, Kim BS, Shin SW, Kim YH, Kim JS. Cancer; 2005 Jun 01; 103(11):2338-43. PubMed ID: 15825161 [Abstract] [Full Text] [Related] Page: [Next] [New Search]